CareDx Inc
CareDx, Inc. (CDNA) is a precision medicine company primarily focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. The company operates within the healthcare sector, particularly emphasizing diagnostics and patient monitoring services. CareDx’s core products include AlloSure, a donor-derived cell-free DNA (dd-cfDNA) test for kidney transplant recipients, and AlloMap, a gene expression profiling test for heart transplant recipients. These innovative solutions aid in the management and improvement of long-term outcomes in transplant patients.